NCT00102544 2026-03-06
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
National Institutes of Health Clinical Center (CC)
Phase NA Enrolling by invitation
Clinical Trials
16 trialsNCT04895748 2026-03-03
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Novartis
Phase 1 Terminated
NCT07405164 2026-02-12
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3 Not yet recruiting
NCT07167329 2025-09-11
BELIEVE-VHL
AC Camargo Cancer Center
Phase 2 Recruiting
NCT06195150 2025-05-01
ITHORinVHL
IRCCS San Raffaele
Recruiting
NCT03108066 2024-09-24
MK-3795-003
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00970970 2024-05-06
VHLimage
University Medical Center Groningen
Completed
NCT06391879 2024-04-30
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Peking University First Hospital
Recruiting
NCT03749980 2024-04-26
MyVHL
VHL Alliance
Recruiting
NCT06194669 2024-01-10
SoMuKT
IRCCS San Raffaele
Recruiting
NCT05534854 2023-08-31
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
RenJi Hospital
Unknown
NCT05843305 2023-05-06
A Study of BPI-452080 in Subjects With Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT00001803 2020-01-13
Von Hippel-Lindau Disease Genetic Epidemiology Study
National Institutes of Health Clinical Center (CC)
Terminated
NCT00088374 2012-07-27
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00075348 2012-03-15
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
National Institutes of Health Clinical Center (CC)
Completed
NCT00001668 2008-03-04
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
National Institutes of Health Clinical Center (CC)
Completed